Susquehanna Portfolio Strategies’s Agilon Health AGL Stock Holding History
Bought
Maintained
Sold
Other funds holding AGL
CDR
NPCM
VCM
Susquehanna Portfolio Strategies's AGL Position: Q1 2026 in Review
Susquehanna Portfolio Strategies sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 4,427 shares — an estimated $76.2K sold.
Susquehanna Portfolio Strategies first reported a position in AGL in Q2 2025 and held it in 3 quarters. The position peaked at $936K in Q2 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.
- Susquehanna Portfolio Strategies reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
- Susquehanna Portfolio Strategies sold 4,427 Agilon Health shares in Q1 2026, an estimated $76.2K.
- Susquehanna Portfolio Strategies first reported a position in Agilon Health in Q2 2025 and held it in 3 quarters.
- Susquehanna Portfolio Strategies's Agilon Health position peaked at $936K in Q2 2025.
- 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.
Based on Susquehanna Portfolio Strategies's 13F filing for Q1 2026, filed 15 May 2026.